FLC
VIVO

Fifth Lane Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Fifth Lane Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-185,914
Closed -$6.17M – 254
2022
Q4 		$6.17M Buy
185,914
+143,814
+342% +$4.63M 5.56% 5
2022
Q3 		$1.33M Buy
+42,100
New +$1.36M 0.69% 23

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fifth Lane Capital's VIVO Position: Q1 2023 in Review

Fifth Lane Capital sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 185,914 shares — an estimated $6.17M sold.

Fifth Lane Capital first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $6.17M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Fifth Lane Capital reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Fifth Lane Capital sold 185,914 Meridian Bioscience Inc shares in Q1 2023, an estimated $6.17M.
  • Fifth Lane Capital first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
  • Fifth Lane Capital's Meridian Bioscience Inc position peaked at $6.17M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Fifth Lane Capital's 13F filing for Q1 2023, filed 15 May 2023.